Reduced mitochondrial-encoded NADH dehydrogenase 6 gene expression drives inflammatory CD4 + T cells in patients with systemic lupus erythematosus
Miheraiy Abdukiyum,Xiaojun Tang,Nan Zhao,Yiyuan Cui,Jingjing Zhang,Tohtihan Alim,Yuanyuan Zheng,Wenjing Li,Mengxi Huang,Xuxue Feng,Honghong Yu,Xuebing Feng
DOI: https://doi.org/10.1016/j.freeradbiomed.2024.01.026
IF: 8.101
2024-01-22
Free Radical Biology and Medicine
Abstract:Abnormal mitochondrial function has been implicated in the progression of systemic lupus erythematosus (SLE), the prototypical autoimmune disease, yet the underlying cause remains unclear. In this study, mitochondrial-encoded NADH dehydrogenase 6 gene (MT-ND6) was identified as having increased m 6 A methylation and decreased expression in peripheral blood mononuclear cells of SLE patients by MeRIP-seq analysis. MT-ND6 expression was negatively correlated with SLE disease activity index score and 24-h urine protein level, and lower in patients with positive anti-Sm or anti-dsDNA antibodies. With the reduction of MT-ND6 levels, CD4 + T cells in SLE patients exhibited mitochondrial dysfunction, as evidenced by increased levels of reactive oxygen species (ROS) and mitochondrial ROS and insufficient ATP production. Accordingly, in vitro MT-ND6 silencing induced abnormalities in the above mitochondrial indicators in CD4 + T cells, and promoted the development of both transcription and inflammatory factors in these cells. In contrast, treatment with targeted mitochondrial antioxidants largely counteracted the silencing effect of MT-MD6. Thus, reduced MT-ND6 in SLE patients may lead to mitochondrial dysfunction through ROS overproduction, thereby promoting inflammatory CD4 + T cells.
biochemistry & molecular biology,endocrinology & metabolism